We are live on ! Find out more
OPU

Omni Partners US Portfolio holdings

AUM $1.95B
This Fund
S&P 500
This Quarter Est. Return
+7.21%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.95B
AUM Growth
-$319M
Cap. Flow
-$362M
Cap. Flow %
-18.57%
Top 10 Hldgs %
50.07%
Holding
304
New
78
Increased
103
Reduced
62
Closed
60

Sector Composition

Rank Sector Weight
1 Financials 18.3%
2 Technology 15.69%
3 Industrials 13.34%
4 Communication Services 11.51%
5 Healthcare 10.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CAHC
276
DELISTED
CA Healthcare Acquisition Corp. Class A Common Stock
CAHC
-228,322
Closed -$2.25M
SOGO
277
DELISTED
Sogou Inc. American Depositary Shares, each representing one Class A Ordinary Share
SOGO
-1,941,866
Closed -$16.6M
SRNG
278
DELISTED
Soaring Eagle Acquisition Corp. Class A Ordinary Share
SRNG
-563,255
Closed -$5.61M
ACIC
279
DELISTED
Atlas Crest Investment Corp.
ACIC
-208,597
Closed -$2.08M
QELL
280
DELISTED
Qell Acquisition Corp. Class A Ordinary Shares
QELL
-609,278
Closed -$6.06M
CENH
281
DELISTED
Centricus Acquisition Corp. Class A Ordinary Share
CENH
-469,168
Closed -$4.64M
PFPT
282
DELISTED
Proofpoint, Inc.
PFPT
-347,840
Closed -$60.4M
KSMT
283
DELISTED
Kismet Acquisition One Corp Ordinary Shares
KSMT
-127,485
Closed -$1.26M
MXIM
284
DELISTED
Maxim Integrated Products
MXIM
-2,220,445
Closed -$234M
RMGB
285
DELISTED
RMG Acquisition Corp. II Class A Ordinary Shares
RMGB
-449,171
Closed -$4.47M
LIVK
286
DELISTED
LIV Capital Acquisition Corp. Class A Ordinary Shares
LIVK
-151,855
Closed -$1.52M
NEBC
287
DELISTED
Nebula Caravel Acquisition Corp. Class A Common Stock
NEBC
-173,390
Closed -$1.73M
TLND
288
DELISTED
Talend S.A. American Depositary Shares
TLND
-959,150
Closed -$62.9M
BPY
289
DELISTED
Brookfield Property Partners L.P. Limited Partnership Units
BPY
-612,199
Closed -$11.6M
HOME
290
DELISTED
At Home Group Inc.
HOME
-716,494
Closed -$26.4M
ALXN
291
DELISTED
Alexion Pharmaceuticals
ALXN
-1,283,115
Closed -$326M
WORK
292
DELISTED
Slack Technologies, Inc.
WORK
-2,514,346
Closed -$111M
CNST
293
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
-1,815,117
Closed -$61.4M
ALUS
294
DELISTED
Alussa Energy Acquisition Corp
ALUS
-95,204
Closed -$943K
FCAC
295
DELISTED
Falcon Capital Acquisition Corp. Class A Common Stock
FCAC
-48,763
Closed -$453K
WTRE
296
DELISTED
Watford Holdings Ltd. Common Shares
WTRE
-713,569
Closed -$25M
PRAH
297
DELISTED
PRA Health Sciences, Inc.
PRAH
-544,675
Closed -$90M
NAV
298
DELISTED
Navistar International
NAV
-1,658,578
Closed -$73.8M
BPFH
299
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
-2,992,815
Closed -$44.1M
GNRS
300
DELISTED
Greenrose Acquisition Corp. Common Stock
GNRS
-802,193
Closed -$8.01M

Similar funds

Omni Partners US's Q3 2021 Portfolio in Review

As of Q3 2021, Omni Partners US held 304 positions worth $1.95B, down 14% from $2.27B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Omni Partners US withdrew a net $362M in Q3 2021, closing 60 positions and reducing 62 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $326M position sold in full.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 17% a quarter earlier, followed by Technology and Industrials.

Against the trend, Omni Partners US opened a new position in Covanta Holding Corporation worth $56.8M.

  • Omni Partners US's largest Q3 2021 buy was Covanta Holding Corporation: 2,822,693 shares worth $56.8M.
  • Omni Partners US added most to Kansas City Southern in Q3 2021, an estimated $127M increase.
  • Omni Partners US's biggest Q3 2021 reduction was Change Healthcare Inc. Common Stock, cutting an estimated $37.2M.
  • Omni Partners US fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $326M.
  • Omni Partners US's ten largest holdings make up 50% of its $1.95B portfolio in Q3 2021.
  • Omni Partners US opened 78 new positions and closed 60 in Q3 2021.
  • Omni Partners US's portfolio value fell 14% quarter-over-quarter to $1.95B.

Based on Omni Partners US's 13F filing for Q3 2021, filed 15 Nov 2021.